Home
About Us
FAQ
Contact Us
Media Tools
ExpertConnect App
MyExpertNet
University Partners
Becoming a Partner
Key Organizations
Search Assistance
Help
Expert Profile
Views:
60
Share
QR code
Edit Profile
Tung Wynn
Clinical Associate Professor
MD-PEDS-HEMATOLOGY | COLLEGE-MEDICINE
View:
Select
All (all in one)
Research Terms and Keywords
Publications
Network
Websites
Contact
All
Research
Publications
Network
Websites
Contact
Research Terms & Keywords
Research Terms
Pediatrics
Research Projects
Ends
Title
09-2023
Public Health Surveillance for the Prevention of Complications of Bleeding Disorders
Public Health Surveillance for the Prevention of Complications of Bleeding Disorders
CTRS FOR DISEASE CONTROL & PREVENTIO
08-2023
ATHN Data Quality Counts (DQC) Program - Round 14
ATHN Data Quality Counts (DQC) Program - Round 14
AMER THROMBOSIS AND HEMOSTASIS NETWORK
06-2023
DISPLACE: Dissemination and Implementation of Stoke Prevention looking at the Care Environment
DISPLACE: Dissemination and Implementation of Stoke Prevention looking at the Care Environment
NATL INST OF HLTH NHLB
06-2023
DISPLACE: Dissemination and Implementation of Stoke Prevention looking at the Care Environment
DISPLACE: Dissemination and Implementation of Stoke Prevention looking at the Care Environment
UNIV OF ALABAMA BIRMINGHA
01-2023
Upper Extremity Exercise to Improve Vascular Volume, Ease of IV Infusions, Factor Compliance, and Quality of Life in Patients with Hemophilia
Upper Extremity Exercise to Improve Vascular Volume, Ease of IV Infusions, Factor Compliance, and Quality of Life in Patients with Hemophilia
NATL HEMOPHILIA FO
09-2022
Public Health Surveillance for the Prevention of Complications of Bleeding Disorders
Public Health Surveillance for the Prevention of Complications of Bleeding Disorders
CTRS FOR DISEASE CONTROL & PREVENTIO
08-2022
ATHN Data Quality Counts (DQC) Program - Round 13
ATHN Data Quality Counts (DQC) Program - Round 13
AMER THROMBOSIS AND HEMOSTASIS NETWORK
05-2022
Southeast Region Comprehensive and Diagnostic Bleeding Treatment Center Program.
Southeast Region Comprehensive and Diagnostic Bleeding Treatment Center Program.
US HLTH RESOURCES AND SERV ADM
09-2021
Public Health Surveillance for the Prevention of Complications of Bleeding Disorders
Public Health Surveillance for the Prevention of Complications of Bleeding Disorders
CTRS FOR DISEASE CONTROL & PREVENTIO
08-2021
ATHN Data Quality Counts (DQC) Award Round 12
ATHN Data Quality Counts (DQC) Award Round 12
AMER THROMBOSIS AND HEMOSTASIS NETWORK
05-2021
Hemophilia Treatment Centers (SPRANS) Southeast Region Maternal and Child Health Bureau (MCHB) Bleeding Disorders Program
Hemophilia Treatment Centers (SPRANS) Southeast Region Maternal and Child Health Bureau (MCHB) Bleeding Disorders Program
HEMOPHILIA OF GEORGI
05-2021
Hemophilia Treatment Centers (SPRANS) Southeast Region Maternal and Child Health Bureau (MCHB) Bleeding Disorders Program
Hemophilia Treatment Centers (SPRANS) Southeast Region Maternal and Child Health Bureau (MCHB) Bleeding Disorders Program
US HLTH RESOURCES AND SERV ADM
09-2020
Public Health Surveillance for the Prevention of Complications of Bleeding and Clotting Disorders
Public Health Surveillance for the Prevention of Complications of Bleeding and Clotting Disorders
CTRS FOR DISEASE CONTROL & PREVENTIO
09-2020
Public Health Surveillance for the Prevention of Complications of Bleeding and Clotting Disorders
Public Health Surveillance for the Prevention of Complications of Bleeding and Clotting Disorders
HEMOPHILIA OF GEORGI
09-2020
Public Health Surveillance for the Prevention of Complications of Bleeding Disorders Project.
Public Health Surveillance for the Prevention of Complications of Bleeding Disorders Project.
CTRS FOR DISEASE CONTROL & PREVENTIO
09-2020
Public Health Surveillance for the Prevention of Complications of Bleeding Disorders Project.
Public Health Surveillance for the Prevention of Complications of Bleeding Disorders Project.
HEMOPHILIA OF GEORGI
08-2020
ATHN Data Quality Counts 10
ATHN Data Quality Counts 10
AMER THROMBOSIS AND HEMOSTASIS NETWORK
05-2020
Southeast Region Comprehensive and Diagnostic Bleeding Treatment Center Program.
Southeast Region Comprehensive and Diagnostic Bleeding Treatment Center Program.
HEMOPHILIA OF GEORGI
05-2020
Southeast Region Comprehensive and Diagnostic Bleeding Treatment Center Program.
Southeast Region Comprehensive and Diagnostic Bleeding Treatment Center Program.
US HLTH RESOURCES AND SERV ADM
02-2020
A Multinational Phase IV Study Evaluating "Real World" Treatment Pattern in Previously Treated Hemophilia A Patients Receiving KOVALTRY (Octocog Alfa) for Routine Prophylaxis
A Multinational Phase IV Study Evaluating "Real World" Treatment Pattern in Previously Treated Hemophilia A Patients Receiving KOVALTRY (Octocog Alfa) for Routine Prophylaxis
BAYER HEALTHCARE
12-2019
Phase 3b Continuation study of the Safety and Efficacy of PEGylated Recombinant Factor VIII (PEG-rFVIII; BAX 855) in Prophylaxis of Bleeding inPreviously Treated Patients with Severe Hemophilia A
Phase 3b Continuation study of the Safety and Efficacy of PEGylated Recombinant Factor VIII (PEG-rFVIII; BAX 855) in Prophylaxis of Bleeding inPreviously Treated Patients with Severe Hemophilia A
BAXTER HEALTHCARE COR
05-2019
Southeast Region Comprehensive and Diagnostic Bleeding Treatment Center Program
Southeast Region Comprehensive and Diagnostic Bleeding Treatment Center Program
HEMOPHILIA OF GEORGI
05-2019
Southeast Region Comprehensive and Diagnostic Bleeding Treatment Center Program
Southeast Region Comprehensive and Diagnostic Bleeding Treatment Center Program
US HLTH RESOURCES AND SERV ADM
09-2018
Public Health Surveillance for the Prevention of Complications of Bleeding and Clotting Disorders
Public Health Surveillance for the Prevention of Complications of Bleeding and Clotting Disorders
CTRS FOR DISEASE CONTROL & PREVENTIO
09-2018
Public Health Surveillance for the Prevention of Complications of Bleeding and Clotting Disorders
Public Health Surveillance for the Prevention of Complications of Bleeding and Clotting Disorders
HEMOPHILIA OF GEORGI
05-2018
Southeast Region Maternal and Child Health Bureau Bleeding Disorders Program
Southeast Region Maternal and Child Health Bureau Bleeding Disorders Program
HEMOPHILIA OF GEORGI
05-2018
Southeast Region Maternal and Child Health Bureau Bleeding Disorders Program
Southeast Region Maternal and Child Health Bureau Bleeding Disorders Program
US HLTH RESOURCES AND SERV ADM
12-2017
Multicenter, open-label, randomised, pharmacokinetic (PK) and pharmacodynamic (PD) dose-ranging Phase II study of ticagrelor followed by a double-blind, randomised, parallel-group, placebo-controlled 4 weeks extension phase in paediatric
Multicenter, open-label, randomised, pharmacokinetic (PK) and pharmacodynamic (PD) dose-ranging Phase II study of ticagrelor followed by a double-blind, randomised, parallel-group, placebo-controlled 4 weeks extension phase in paediatric
ASTRAZENEC
12-2017
Multicenter, open-label, randomised, pharmacokinetic (PK) and pharmacodynamic (PD) dose-ranging Phase II study of ticagrelor followed by a double-blind, randomised, parallel-group, placebo-controlled 4 weeks extension phase in paediatric
Multicenter, open-label, randomised, pharmacokinetic (PK) and pharmacodynamic (PD) dose-ranging Phase II study of ticagrelor followed by a double-blind, randomised, parallel-group, placebo-controlled 4 weeks extension phase in paediatric
ICON CLINICAL RESEARCH IN
10-2017
30-day, open-label, active-controlled, randomized study of the safety, efficacy and the pharmacokinetic and pharmacodynamic properties of oral rivaroxaban in young children with various manifestations of venous thrombosis
30-day, open-label, active-controlled, randomized study of the safety, efficacy and the pharmacokinetic and pharmacodynamic properties of oral rivaroxaban in young children with various manifestations of venous thrombosis
BAYER HEALTHCARE PHARMACEUTICAL
10-2017
Multicenter, open-label, active-controlled, randomized study to evaluate the efficacy and safety of an age-and body weight-adjusted rivaroxaban regimen compared to standard of care in children with acute venous thromboembolism
Multicenter, open-label, active-controlled, randomized study to evaluate the efficacy and safety of an age-and body weight-adjusted rivaroxaban regimen compared to standard of care in children with acute venous thromboembolism
BAYER HEALTHCARE PHARMACEUTICAL
09-2017
Community Counts Public Health Surveillance for Bleeding Disorders Project
Community Counts Public Health Surveillance for Bleeding Disorders Project
CTRS FOR DISEASE CONTROL & PREVENTIO
09-2017
Community Counts Public Health Surveillance for Bleeding Disorders Project
Community Counts Public Health Surveillance for Bleeding Disorders Project
HEMOPHILIA OF GEORGI
07-2017
A PHASE 3 PROSPECTIVE, UNCONTROLLED, MULTICENTER STUDY EVALUATING PHARMACOKINETICS, EFFICACY, SAFETY, AND IMMUNOGENICITY OF BAX 855 (PEGYLATEDFULL-LENGTH RECOMBINANT FVIII) IN PREVIOUSLY TREATED PEDIATRIC PATIENTS WITH SEVERE HEMOPHILIA A
A PHASE 3 PROSPECTIVE, UNCONTROLLED, MULTICENTER STUDY EVALUATING PHARMACOKINETICS, EFFICACY, SAFETY, AND IMMUNOGENICITY OF BAX 855 (PEGYLATEDFULL-LENGTH RECOMBINANT FVIII) IN PREVIOUSLY TREATED PEDIATRIC PATIENTS WITH SEVERE HEMOPHILIA A
BAXTER INTERNATIONAL
07-2017
A PHASE 3 PROSPECTIVE, UNCONTROLLED, MULTICENTER STUDY EVALUATING PHARMACOKINETICS, EFFICACY, SAFETY, AND IMMUNOGENICITY OF BAX 855 (PEGYLATEDFULL-LENGTH RECOMBINANT FVIII) IN PREVIOUSLY TREATED PEDIATRIC PATIENTS WITH SEVERE HEMOPHILIA A
A PHASE 3 PROSPECTIVE, UNCONTROLLED, MULTICENTER STUDY EVALUATING PHARMACOKINETICS, EFFICACY, SAFETY, AND IMMUNOGENICITY OF BAX 855 (PEGYLATEDFULL-LENGTH RECOMBINANT FVIII) IN PREVIOUSLY TREATED PEDIATRIC PATIENTS WITH SEVERE HEMOPHILIA A
QUINTILES IN
05-2017
Southeast Region Comprehensive and Diagnostic Bleeding Disorders Treatment Center Program
Southeast Region Comprehensive and Diagnostic Bleeding Disorders Treatment Center Program
HEMOPHILIA OF GEORGI
05-2017
Southeast Region Comprehensive and Diagnostic Bleeding Disorders Treatment Center Program
Southeast Region Comprehensive and Diagnostic Bleeding Disorders Treatment Center Program
US HLTH RESOURCES AND SERV ADM
04-2017
Single-dose pilot study of oral rivaroxaban in pediatric subjects with venous thromboembolism.
Single-dose pilot study of oral rivaroxaban in pediatric subjects with venous thromboembolism.
BAYER HEALTHCARE PHARMACEUTICAL
01-2017
A Phase 3, Multi-Center, Open Label Study of Efficacy and Safety of PEGylated rFVIII (BAX855) in Previously Treated Patients with Severe Hemophilia A Undergoing Surgical or Other Invasive Procedures
A Phase 3, Multi-Center, Open Label Study of Efficacy and Safety of PEGylated rFVIII (BAX855) in Previously Treated Patients with Severe Hemophilia A Undergoing Surgical or Other Invasive Procedures
BAXALTA US
01-2017
A Phase 3, Multi-Center, Open Label Study of Efficacy and Safety of PEGylated rFVIII (BAX855) in Previously Treated Patients with Severe Hemophilia A Undergoing Surgical or Other Invasive Procedures
A Phase 3, Multi-Center, Open Label Study of Efficacy and Safety of PEGylated rFVIII (BAX855) in Previously Treated Patients with Severe Hemophilia A Undergoing Surgical or Other Invasive Procedures
QUINTILES IN
01-2016
Guardian 4
Guardian 4
NOVO NORDISK
06-2015
PEGylated rFVIII (BAX 855)
PEGylated rFVIII (BAX 855)
BAXTER HEALTHCARE COR
Publications
OpenAlex
Search Engines
Last updated on 7/21/25. See our
OpenAlex FAQ
for more about this data.
Search Google Scholar for Tung Wynn
OpenAlex Works Search
Co-Investigator Network
Anita Rajasekhar
Professor
University of Florida
Md-Hematology-Oncology, College-Medicine
rajasa@medicine.ufl.edu
Inactive Expert
Lucien Black
Clinical Associate Professor
University of Florida
Vm-Phy Sci, Pediatrics
Inactive Expert
Amy Ramirez
Ops-Spons Prjs Non-Clerical
University of Florida
Md-Peds-Administration, College-Medicine
Expertnet Author Network
Experts within Florida Expertnet that have co-authored works with Tung Wynn.
Inactive Expert
Lung-Ji Chang
Professor
University of Florida
Md-Molecular Gentcs - Microbio, College-Medicine
Works Co-Authored: 39
Nancy Mendenhall
Professor and Associate Chair
University of Florida
Md-Radiation Oncology, College-Medicine
menden@shands.ufl.edu
Works Co-Authored: 556
William Slayton
Professor
University of Florida
Md-Peds-Hematology, College-Medicine
wslayton@ufl.edu
Works Co-Authored: 140
Inactive Expert
Roland Herzog
Associate Professor
University of Florida
Md-Peds-Cell - Molec Therp Div, College-Medicine
Works Co-Authored: 62
Mark Bleiweis
William G. Lassiter Jr. and Aneice R. Lassiter Professor and Director, Uf Health Congenital Heart Center
University of Florida
Md-Surgery-Tcv-Cardiovasc, College-Medicine
bleiweis@ufl.edu
Works Co-Authored: 206
Daniel Indelicato
Professor
University of Florida
Md-Radiation Oncology, College-Medicine
dindelicato@floridaproton.org
Works Co-Authored: 739
Joanne Lagmay
Professor; Interim Chief; Stop Children's Cancer Of Palm Beach County, Inc. Professorship in Pediatric Oncology
University of Florida
Md-Peds-Hematology, College-Medicine
jplagmay@peds.ufl.edu
Works Co-Authored: 45
Anita Rajasekhar
Professor
University of Florida
Md-Hematology-Oncology, College-Medicine
rajasa@medicine.ufl.edu
Works Co-Authored: 79
Julie Bradley
Professor
University of Florida
Md-Radiation Oncology, College-Medicine
juliekb@ufl.edu
Works Co-Authored: 235
Ramzi Salloum
Professor and Associate Chair For Research; Division Chief For Implementation Science
University of Florida
Md-Hobi-General, College-Medicine
rsalloum@ufl.edu
Works Co-Authored: 295
Inactive Expert
Ronny Rotondo
Assistant Professor
University of Florida
Md-Proton Beam, College-Medicine
Works Co-Authored: 80
Dhanashree Rajderkar
Academic Lump Sum Payment
University of Florida
Md-Cme, College-Medicine
drajderkar@ufl.edu
Works Co-Authored: 97
Scott Vouri
Assistant Professor
University of Florida
Ph-Pharm Outcomes & Policy, College-Pharmacy
svouri@ufl.edu
Works Co-Authored: 122
Molly Weidner Mandernach
Professor
University of Florida
Md-Hematology-Oncology, College-Medicine
mweidner@ufl.edu
Works Co-Authored: 30
Inactive Expert
John Fort
Clinical Associate Professor
University of Florida
Md-Peds-Hematology, College-Medicine
Works Co-Authored: 44
George Arnaoutakis
Associate Professor
University of Florida
Phhp-Com Epidemiology, Phhp-Com Integrated Programs
gja10@ufl.edu
Works Co-Authored: 271
Rachel Reise
Clinical Assistant Professor
University of Florida
Ph-Pharm Outcomes & Policy, College-Pharmacy
rreise@ufl.edu
Works Co-Authored: 11
Giles Peek
Professor
University of Florida
Md-Surgery-Tcv-Cardiovasc, College-Medicine
gilespeek@ufl.edu
Works Co-Authored: 323
Brian Stover
Assistant Professor
University of Florida
Md-Peds-Hematology, College-Medicine
bstover@ufl.edu
Works Co-Authored: 24
Reem Kashif
Clinical Assistant Professor, Director Of Sickle Cell Disease Program, and Pediatric Clerkship Core Faculty Member
University of Florida
Md-Peds-Hematology, College-Medicine
reema.kashif@ufl.edu
Works Co-Authored: 15
Ofelia Alvarez
University of Miami
Pediatrics, Medical
oalvarez2@miami.edu
Works Co-Authored: 117
Fernando Corrales Medina
University of Miami
Pediatrics, Medical
ffc5@miami.edu
Works Co-Authored: 55
Websites
ORCID 0000-0002-7331-4364
OpenAlex Works Search
Search Google Scholar for Tung Wynn
Contact Information
twynn@ufl.edu
3522739120
PO BOX 100298 GAINESVILLE, FL 326100001
Profile QR code
What is this?
Keyword Search
Please enter valid search criteria.
Search
Centers
Experts
Projects
Speakers
Stories
Technologies
Videos
University
All Universities
Florida A&M University
Florida Atlantic University
Florida Gulf Coast University
Florida Institute of Technology
Florida International University
Florida State University
University of Central Florida
University of Florida
University of Miami
University of North Florida
University of South Florida
University of West Florida
Browse by STEM
Biotechnology
Computer Science
Energy
Engineering
Environmental Sciences
Information Science
Life Sciences
Mathematics
Medical Sciences
Military Sciences
Natural Sciences
Physical Sciences
Plant Sciences
Science
Space Sciences
Technology
Transportation
